Computational tool for the early screening of monoclonal antibodies for their viscosities

Highly concentrated antibody solutions often exhibit high viscosities, which present a number of challenges for antibody-drug development, manufacturing and administration. The antibody sequence is a key determinant for high viscosity of highly concentrated solutions; therefore, a sequence- or structure-based tool that can identify highly viscous antibodies from their sequence would be effective in ensuring that only antibodies with low viscosity progress to the development phase. Here, we present a spatial charge map (SCM) tool that can accurately identify highly viscous antibodies from their sequence alone (using homology modeling to determine the 3-dimensional structures). The SCM tool has been extensively validated at 3 different organizations, and has proved successful in correctly identifying highly viscous antibodies. As a quantitative tool, SCM is amenable to high-throughput automated analysis, and can be effectively implemented during the antibody screening or engineering phase for the selection of low-viscosity antibodies.

[1]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[2]  Sandeep Yadav,et al.  The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions. , 2012, Molecular pharmaceutics.

[3]  Theodore W Randolph,et al.  Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation. , 2010, Journal of pharmaceutical sciences.

[4]  Anuj Chaudhri,et al.  Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations. , 2015, Molecular pharmaceutics.

[5]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[6]  Bernhardt L. Trout,et al.  Design of therapeutic proteins with enhanced stability , 2009, Proceedings of the National Academy of Sciences.

[7]  Steven J. Shire,et al.  Viscosity Analysis of High Concentration Bovine Serum Albumin Aqueous Solutions , 2011, Pharmaceutical Research.

[8]  Sandeep Yadav,et al.  Specific interactions in high concentration antibody solutions resulting in high viscosity. , 2010, Journal of pharmaceutical sciences.

[9]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[10]  Thomas M. Dillon,et al.  Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass* , 2008, Journal of Biological Chemistry.

[11]  Herren Wu,et al.  Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)* , 2006, Journal of Biological Chemistry.

[12]  Bernhardt L Trout,et al.  Developability index: a rapid in silico tool for the screening of antibody aggregation propensity. , 2012, Journal of pharmaceutical sciences.

[13]  Gregory A Voth,et al.  The role of amino acid sequence in the self-association of therapeutic monoclonal antibodies: insights from coarse-grained modeling. , 2013, The journal of physical chemistry. B.

[14]  Sandeep Yadav,et al.  Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. , 2010, Journal of pharmaceutical sciences.

[15]  A R Rees,et al.  WAM: an improved algorithm for modelling antibodies on the WEB. , 2000, Protein engineering.

[16]  Ken A. Dill,et al.  In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability , 2014, Proceedings of the National Academy of Sciences.

[17]  Li Li,et al.  Concentration Dependent Viscosity of Monoclonal Antibody Solutions: Explaining Experimental Behavior in Terms of Molecular Properties , 2014, Pharmaceutical Research.

[18]  Li Li,et al.  Rational design of viscosity reducing mutants of a monoclonal antibody: Hydrophobic versus electrostatic inter-molecular interactions , 2015, mAbs.

[19]  Steven J Shire,et al.  Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. , 2005, Journal of pharmaceutical sciences.